In the UK, individuals with Attention-Deficit Hyperactivity Disorder (ADHD) experience significant challenges in managing their finances. Laura Bush, a 31-year-old woman from Norwich, faced overwhelming difficulties regarding her financial situation after obtaining a credit card prior to her ADHD diagnosis in 2023. She described the anxiety and shame stemming from her debt as consuming, as ADHD can lead to executive dysfunction, impacting an individual's ability to focus on tasks like budgeting and managing repayments effectively. This situation is not unique to her, as many adults with ADHD encounter similar conditions, often resulting in what is referred to as the 'ADHD tax.' This term encompasses financial penalties incurred through late fees, impulsive spending, or lost items that disrupt daily life and financial stability. Nevaeh Denby, a 24-year-old hospital administrator from Gorleston, Norfolk, shared her experience of feeling unable to manage her finances effectively compared to her peers while studying at university. She expressed her fears regarding the long-term impact of her ADHD on her ability to build a stable life, voicing concerns about how it affects her partner and family. Angela, a 34-year-old woman diagnosed with ADHD at 29, highlighted the considerable costs associated with reasonable adjustments needed due to her neurodivergence. Based on these testimonies, it is evident that ADHD can impose significant emotional burdens and feelings of shame on individuals, especially when societal expectations clash with their struggles to handle financial responsibilities adequately. In a wider context, a survey by StepChange found that over 60% of neurodivergent respondents had not sought guidance from lenders or debt specialists. Financial service representatives in the UK are working towards improving support for neurodivergent customers by offering tailored services and clearer communication. On the other side of the Atlantic, the U.S. is facing a crisis concerning the supply of medications used to treat ADHD. Millions of Americans who rely on these medications are facing shortages due to supply chain disruptions following the COVID-19 pandemic. Numerous patients are left with limited options, which leads to potential impairments in concentration and overall productivity, exacerbating their condition. The compounded effects of both financial struggles and medication shortages illustrate the pressing need for systemic changes to support individuals with ADHD effectively.